NCT00802815View on ClinicalTrials.gov

Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Inclusion Body Myositis
Interventions
DRUG

Etanercept

50 milligrams subcutaneously every week

Trial Locations (1)

63110

Washington University Department of Neurology, St Louis

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

Washington University School of Medicine

OTHER